Labour hire company WorkPac has been hit with a class action on behalf of hundreds of casual miners who claim they were denied annual leave and other entitlements.
Sanofi slams judge’s harm assessment in denying injector pen injunction
ASIC targets AMP execs in fees for no service probe, court told
Acciona mulls settlement with NSW Government in light rail dispute
AMP contractor pleads guilty to stealing customer data
Wyeth defends validity of patents in trial over best-selling Prevnar 13 vaccine
Pharmaceutical giant Wyeth has shot down arguments by rival Merck Sharp & Dohme that its Prevnar 13 vaccine lacked inventiveness, saying during the closing submissions of a high-stakes patent trial that up until it developed the top-selling shot scientists thought there was a “ceiling” of 11 types of pneumococcal bacteria that could be included in a single vaccine.